What We're Reading: Page 161
Industry reads hand-picked by our editors
Jun 08, 2021
-
The Wall Street Journal
Millions of J&J Covid-19 Vaccines Are at Risk of Expiring in June
-
POLITICO
Biden to shore up supply chains for four sectors after 100-day reviews
-
Reuters
Pfizer to test COVID-19 vaccine in larger group of children below 12
-
FierceBiotech
Bayer's billion-dollar Parkinson's disease bets land in the clinic
Jun 07, 2021
Jun 04, 2021
-
Evaluate Vantage
Asco 2021 – financial toxicity in the spotlight
-
Vanity Fair
The Lab-Leak Theory: Inside the Fight to Uncover COVID-19’s Origins
-
The Financial Times
Vulnerable people may need vaccine boosters this year, scientists say
-
STAT
Martin Shkreli's longtime friend wants to undo his 4,000% price hike
Jun 03, 2021
-
Barron's
Novavax Says Data From Its U.S. Phase 3 Trial Is Coming Soon
-
The Wall Street Journal
Immunocompromised People Turn to Covid-19 Vaccine Booster Shots
-
Endpoints News
A simple patient survey revolutionized ALS drug development in the 1990s. Its creator says it may be time for an upgrade
-
The New York Times
Ejected from a troubled plant, AstraZeneca is in talks to produce vaccine for U.S. government at a different factory.
Jun 02, 2021
-
Science
Israel reports link between rare cases of heart inflammation and COVID-19 vaccination in young men
-
The New York Times
Editor of JAMA Leaves After Outcry Over Colleague’s Remarks on Racism
-
The Guardian
Sacklers deny responsibility for opioid crisis and claim lawyers ‘invented false narrative’
Jun 01, 2021
-
The Washington Post
Alzheimer’s drug sparks emotional battle as FDA nears deadline on whether to approve
-
Life Sci VC
Biotech’s Relevancy Challenge In An Expanding Universe
-
Reuters
Even after U.S. shift, opponents resist COVID-19 vaccine patent waiver
-
STAT
The name game for coronavirus variants just got a little easier
May 28, 2021
-
Science
Rich countries cornered COVID-19 vaccine doses. Four strategies to right a 'scandalous inequity'
-
Endpoints News
FDA adcomm votes in favor of approving Provention Bio's drug to delay type 1 diabetes
-
The Wall Street Journal
FDA, J&J Near Deal for Covid-19 Vaccine Production at Baltimore Plant
-
Evaluate Vantage
Bristol joins fast-growing ulcerative colitis market
Previous
